PP088. Oral antihypertensive therapy for severe hypertension in pregnancy

2012 ◽  
Vol 2 (3) ◽  
pp. 288 ◽  
Author(s):  
T. Firoz ◽  
L.A. Magee ◽  
S. Lalani ◽  
D. Sawchuck ◽  
B. Payne ◽  
...  
2015 ◽  
Vol 35 (4) ◽  
pp. 179-180
Author(s):  
T. Firoz ◽  
L.A. Magee ◽  
K. MacDonell ◽  
B.A. Payne ◽  
R. Gordon ◽  
...  

2022 ◽  
Vol 226 (1) ◽  
pp. S282
Author(s):  
Allison M. Davis ◽  
Christina T. Blanchard ◽  
Akila Subramaniam ◽  
Rachel G. Sinkey ◽  
Alan T. Tita ◽  
...  

2019 ◽  
Vol 7 ◽  
pp. 205031211984370 ◽  
Author(s):  
Stephanie Braunthal ◽  
Andrei Brateanu

Hypertensive disorders of pregnancy, an umbrella term that includes preexisting and gestational hypertension, preeclampsia, and eclampsia, complicate up to 10% of pregnancies and represent a significant cause of maternal and perinatal morbidity and mortality. Despite the differences in guidelines, there appears to be consensus that severe hypertension and non-severe hypertension with evidence of end-organ damage need to be controlled; yet the ideal target ranges below 160/110 mmHg remain a source of debate. This review outlines the definition, pathophysiology, goals of therapy, and treatment agents used in hypertensive disorders of pregnancy.


Sign in / Sign up

Export Citation Format

Share Document